Home › Lung Cancer › Idaho › Meridian
Lung Cancer clinical trials in Meridian, ID
4 studies for Lung Cancer are looking for participants at sites in and around Meridian (within about 30 miles). Open a study to see who can join and how to contact the study team.
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
RecruitingPhase 3
- Saint Luke's Cancer Institute - Meridian, Meridian
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
RecruitingPhase 3
- Saint Luke's Cancer Institute - Meridian, Meridian
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Idaho Urologic Institute-Meridian, Meridian
- Saint Luke's Cancer Institute - Meridian, Meridian
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
RecruitingPhase 2/3
- Idaho Urologic Institute-Meridian, Meridian
- Saint Luke's Cancer Institute - Meridian, Meridian
About Lung Cancer
Lung cancer forms in tissues of the lung, usually in the cells that line the air passages. It is the leading cause of cancer death in both men and women.
More about Lung Cancer on MedlinePlus
Lung Cancer trials in other cities
- Houston, TX78 studies
- Boston, MA62 studies
- New York City, NY60 studies
- Los Angeles, CA45 studies
- Washington, DC41 studies
- Chicago, IL41 studies
- Arlington, VA40 studies
- Nashville, TN40 studies
- Baltimore, MD40 studies
- St. Louis, MO39 studies
- Columbus, OH36 studies
- Philadelphia, PA36 studies
Other studies in Meridian
- Obesity8 studies
- Prostate Cancer7 studies
- Overweight7 studies
- Acute Myeloid Leukemia6 studies
- Atherosclerosis5 studies
- Colorectal Cancer4 studies
- Non-Small Cell Lung Cancer4 studies
- Cardiovascular Disease3 studies
- Head and Neck Squamous Cell Carcinoma3 studies
- Eczema3 studies
- Endometrial Cancer3 studies
- Melanoma3 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.